Median overall survival of 15.9 months in Cyclin E1-positive PROC, with 1–5 prior lines of therapy; safety profile in DENALI Part 1b was ...
Zentalis Pharmaceuticals reported 15.9-month median survival in Cyclin E1-positive ovarian cancer patients treated with ...
Microsoft’s AI Stuns Doctors: 83.2% Accuracy in Complex Cases”, “content”: “ Imagine a world where the most perplexing ...
University of New Haven graduate candidate Muhammad Ali ’27 MPH reflects on attending the 2026 SOPHE Advocacy Summit in Washington, D.C., where he developed advocacy skills, met public health ...
Spread the loveCollege life in 2023 is a whirlwind, isn’t it? Between lectures, labs, papers, and trying to maintain some ...
The event convened over 1,080 exhibitors, 1,400 brands and 54,000 professionals, focusing on international collaboration ...
Artificial intelligence is giving advisors something they can never buy more of—time. The firms embracing AI aren’t replacing ...